UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

PB1886 THE TRANSMEMBRANE RECEPTOR TYROSINE KINASE‐LIKE ORPHAN RECEPTOR 1 IN CHRONIC LYMPHOCYTIC LEUKEMIA

HemaSphere, 2019-06, Vol.3 (S1), p.859-n/a

2019

Volltextzugriff (PDF)

Treatment of aplastic anemia: Experience of İbn-i Sina Hospital

Turkish journal of haematology, 2001, Vol.18 (1), p.33-40

2001

Volltextzugriff (PDF)

Myeloma as a Second Malignancy following AML: Is a Second Allo Equivalent to Auto?

Case Reports in Medicine, 2012-01, Vol.2012 (2012), p.1-3-089

2012

Volltextzugriff (PDF)

A Rare Lymphoproliferative Disease: Castleman Disease

Turkish journal of haematology, 2021-01, Vol.38 (4), p.314-320

2021

Volltextzugriff (PDF)

Thiol-disulphide Homeostasis in Essential Thrombocythemia Patients

Journal of medical biochemistry, 2019-10, Vol.38 (4), p.475-480

2019

Volltextzugriff (PDF)

How to manage poor mobilizers for high dose chemotherapy and autologous stem cell transplantation?

Transfusion and apheresis science, 2017-04, Vol.56 (2), p.190-198

2017

Volltextzugriff (PDF)

VAD Chemotherapy Versus Bortezomib Containing Regimens As Remission Induction For ASCT in Multiple Myeloma: A Single Center Experience

International journal of hematology- oncology and stem cell research, 2020-10, Vol.14 (4), p.248-256

2020

Volltextzugriff (PDF)

Lupus-like symptoms with anti-RNP/Sm and anti-nuclear antibodies positivity: An extremely rare adverse event of dasatinib

Journal of oncology pharmacy practice, 2020-04, Vol.26 (3), p.738-741

2020

Volltextzugriff (PDF)

Post-Induction Undetectable Minimal Residual Disease at 10 -5 Sensitivity Level within Marrow and/or Stem Cell Graft Overrides Cytogenetic High Risk

Blood, 2021-11, Vol.138 (Supplement 1), p.2909-2909

2021

Volltextzugriff (PDF)

Acquired hemophilia with thrombosis in a cancer patient: an unusual presentation

Blood coagulation & fibrinolysis, 2018-01, Vol.29 (1), p.129-130

2018

Volltextzugriff (PDF)

Vitamin D Deficiency and Janus kinase 2 V617F Mutation Status in Essential Thrombocythemia and Polycythemia Vera

The Malaysian journal of medical sciences, 2020-02, Vol.27 (1), p.70-77

2020

Volltextzugriff (PDF)

Is Cd11c and Fmc7 Negativity in Chronic Lymphocytic Leukemia Poor Prognostic?

Indian journal of hematology & blood transfusion, 2020-01, Vol.36 (1), p.84-90

2020

Volltextzugriff (PDF)

Predictive Factors for Molecular Response in Chronic Myeloid Leukemia: Reduction Ratio and Halving time of BCR::ABL1 IS Transcript Levels

Turkish journal of haematology, 2022-08, Vol.39 (3), p.196-203

2022

Volltextzugriff (PDF)

Prognostic Value of the Expression of Receptor Tyrosine Kinase-Like Orphan Receptor 1 (ROR-1) in Chronic Lymphocytic Leukemia

International journal of hematology- oncology and stem cell research, 2023, Vol.17 (1), p.39-47

2023

Volltextzugriff (PDF)

Development of plasma cell leukemia in a patient with chronic myeloid leukemia while on treatment with imatinib mesylate

Journal of cancer research and therapeutics, 2018-10, Vol.14 (6), p.1431-1433

2018

Volltextzugriff (PDF)

P-132 Post-induction undetectable flow minimal residual disease ameliorates the high risk determined by FISH among newly diagnosed multiple myeloma

Clinical lymphoma, myeloma and leukemia, 2023-09, Vol.23, p.S108-S108

2023

Volltextzugriff (PDF)

The Triple Positivity for EBV, PD-1, and PD-L1 Identifies a Very High Risk Classical Hodgkin Lymphoma

Clinical lymphoma, myeloma and leukemia, 2020-07, Vol.20 (7), p.e375-e381

2020

Volltextzugriff (PDF)

Comparison of low dose cytosine arabinoside, azacitidine and azacitidine venetoclax combination treatment as remission induction in elderly acute myeloid leukemia patients

Journal of Medicine and Palliative Care, 2023-12, Vol.4 (6), p.619-624

2023

Volltextzugriff (PDF)

Leukemia: Reduction Ratio and Halving Time of BCR: : ABL1 IS Transcript Levels

Turkish journal of haematology, 2022-08, Vol.39 (3), p.196-203

2022

Volltextzugriff (PDF)

Residual Clonal Plasma Cells Detected By Flow Cytometry at 10-4level within Autologous Stem Cell Grafts Is Associated with Significantly Less Overall Survival

Blood, 2018-11, Vol.132 (Supplement 1), p.3438-3438

2018

Volltextzugriff (PDF)

P-038: Postinduction minimal residual disease (MRD) within stem cell graft (gMRD) correlates with marrow MRD (mMRD) and progression free survival (PFS) following autologous stem cell transplantation

Clinical lymphoma, myeloma and leukemia, 2021-10, Vol.21, p.S59-S59

2021

Volltextzugriff (PDF)

The least incompatible crossmatch red blood cell transfusion by biological compatibility test

Global Journal of Transfusion Medicine, 2019-01, Vol.4 (2), p.154-157

2019

Volltextzugriff (PDF)

Impact of PET-CT Response on Survival Parameters Following Autologous Stem Cell Transplantation Among Patients with Multiple Myeloma: Comparison of Two Cut-Off Values

Blood, 2014-12, Vol.124 (21), p.3983-3983

2014

Volltextzugriff (PDF)

Relationship between mannose-binding lectin and febrile neutropenia in acute leukemia patients

Annals of Clinical and Analytical Medicine, 2020-09, Vol.11 (5)

2020

Volltextzugriff (PDF)

1 – 25 von 57

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(45)
Mit Volltextzugriff
(49)

Publikationsform

Sprache

Englisch
(56)
Koreanisch
(1)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(21)
Science & Technology
(21)
Hematology
(16)
Humans
(11)
Male
(7)
Adult
(5)
Female
(5)
Leukemia
(5)
Chronic Myeloid Leukemia
(4)
Medical Prognosis
(4)
Oncology
(4)
Original
(4)
Aged
(3)
General & Internal Medicine
(3)
Health Technology Assessment
(3)
Hematology, Oncology And Palliative Medicine
(3)
Medicine, General & Internal
(3)
Middle Aged
(3)
Patients
(3)
Thrombosis
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

PB1886 THE TRANSMEMBRANE RECEPTOR TYROSINE KINASE‐LIKE ORPHAN RECEPTOR 1 IN CHRONIC LYMPHOCYTIC LEUKEMIA

Treatment of aplastic anemia: Experience of İbn-i Sina Hospital

Myeloma as a Second Malignancy following AML: Is a Second Allo Equivalent to Auto?

A Rare Lymphoproliferative Disease: Castleman Disease

Thiol-disulphide Homeostasis in Essential Thrombocythemia Patients

Castleman Disease: A Multicenter Case Series from Turkey

How to manage poor mobilizers for high dose chemotherapy and autologous stem cell transplantation?

VAD Chemotherapy Versus Bortezomib Containing Regimens As Remission Induction For ASCT in Multiple Myeloma: A Single Center Experience

Lupus-like symptoms with anti-RNP/Sm and anti-nuclear antibodies positivity: An extremely rare adverse event of dasatinib

Post-Induction Undetectable Minimal Residual Disease at 10 -5 Sensitivity Level within Marrow and/or Stem Cell Graft Overrides Cytogenetic High Risk

Acquired hemophilia with thrombosis in a cancer patient: an unusual presentation

Vitamin D Deficiency and Janus kinase 2 V617F Mutation Status in Essential Thrombocythemia and Polycythemia Vera

Is Cd11c and Fmc7 Negativity in Chronic Lymphocytic Leukemia Poor Prognostic?

Predictive Factors for Molecular Response in Chronic Myeloid Leukemia: Reduction Ratio and Halving time of BCR::ABL1 IS Transcript Levels

Prognostic Value of the Expression of Receptor Tyrosine Kinase-Like Orphan Receptor 1 (ROR-1) in Chronic Lymphocytic Leukemia

Development of plasma cell leukemia in a patient with chronic myeloid leukemia while on treatment with imatinib mesylate

P-132 Post-induction undetectable flow minimal residual disease ameliorates the high risk determined by FISH among newly diagnosed multiple myeloma

The Triple Positivity for EBV, PD-1, and PD-L1 Identifies a Very High Risk Classical Hodgkin Lymphoma

Comparison of low dose cytosine arabinoside, azacitidine and azacitidine venetoclax combination treatment as remission induction in elderly acute myeloid leukemia patients

Leukemia: Reduction Ratio and Halving Time of BCR: : ABL1 IS Transcript Levels

Residual Clonal Plasma Cells Detected By Flow Cytometry at 10-4level within Autologous Stem Cell Grafts Is Associated with Significantly Less Overall Survival

P-038: Postinduction minimal residual disease (MRD) within stem cell graft (gMRD) correlates with marrow MRD (mMRD) and progression free survival (PFS) following autologous stem cell transplantation

The least incompatible crossmatch red blood cell transfusion by biological compatibility test

Impact of PET-CT Response on Survival Parameters Following Autologous Stem Cell Transplantation Among Patients with Multiple Myeloma: Comparison of Two Cut-Off Values

Relationship between mannose-binding lectin and febrile neutropenia in acute leukemia patients

Suchergebnisse filtern